Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer.


Journal Article

OBJECTIVE: We have previously shown that TCEAL7 (transcription elongation factor A (SII)-like 7) is epigenetically down-regulated in the majority of epithelial ovarian cancers. We now examine the hypothesis that inherited alterations in TCEAL7 play a role in the etiology of ovarian cancer. METHODS: A two-site case-control study of 930 cases of ovarian cancer and 1037 controls, frequency-matched on residence, age and race, was conducted. Six informative SNPs (tagSNPs and putative-functional SNPs) were genotyped. Logistic regression was used to adjust for potential confounders and determine if inherited variation at this locus was associated with risk of ovarian cancer in general and among cases with invasive disease and serous histology. Gene-level principal component and haplotype analyses were also conducted. RESULTS: None of the SNPs or haplotypes studied were significantly associated with ovarian cancer risk overall. However, among the 440 invasive serous cases, the minor alleles for three correlated SNPs were significantly associated with reduced risk (p-values<0.05), summarized gene-level variation was weakly associated with reduced risk (p-value=0.05), and the predominant haplotype was less common among cases than controls (0.36 v 0.40, p-value=0.05), consistent with single-SNP results. CONCLUSION: TCEAL7 polymorphisms may play a role in the development of invasive serous ovarian cancers. Follow-up molecular and replication studies are warranted.

Full Text

Duke Authors

Cited Authors

  • Peedicayil, A; Vierkant, RA; Shridhar, V; Schildkraut, JM; Armasu, S; Hartmann, LC; Fridley, BL; Cunningham, JM; Phelan, CM; Sellers, TA; Goode, EL

Published Date

  • August 2009

Published In

Volume / Issue

  • 114 / 2

Start / End Page

  • 260 - 264

PubMed ID

  • 19419758

Pubmed Central ID

  • 19419758

Electronic International Standard Serial Number (EISSN)

  • 1095-6859

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2009.03.038


  • eng

Conference Location

  • United States